BE641151A - - Google Patents

Info

Publication number
BE641151A
BE641151A BE641151A BE641151A BE641151A BE 641151 A BE641151 A BE 641151A BE 641151 A BE641151 A BE 641151A BE 641151 A BE641151 A BE 641151A BE 641151 A BE641151 A BE 641151A
Authority
BE
Belgium
Application number
BE641151A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE641151A publication Critical patent/BE641151A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/256—Polyterpene radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE641151A 1962-12-14 1963-12-12 BE641151A (cg-RX-API-DMAC7.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEM55118A DE1282852B (de) 1962-12-14 1962-12-14 Peroral anwendbares aescinhaltiges Arzneimittel
CH1488763 1963-12-06

Publications (1)

Publication Number Publication Date
BE641151A true BE641151A (cg-RX-API-DMAC7.html) 1964-04-01

Family

ID=25715271

Family Applications (1)

Application Number Title Priority Date Filing Date
BE641151A BE641151A (cg-RX-API-DMAC7.html) 1962-12-14 1963-12-12

Country Status (10)

Country Link
US (1) US3238104A (cg-RX-API-DMAC7.html)
AT (1) AT245733B (cg-RX-API-DMAC7.html)
BE (1) BE641151A (cg-RX-API-DMAC7.html)
CH (1) CH474541A (cg-RX-API-DMAC7.html)
DE (2) DE1282852B (cg-RX-API-DMAC7.html)
DK (1) DK107183C (cg-RX-API-DMAC7.html)
FR (1) FR3473M (cg-RX-API-DMAC7.html)
GB (1) GB1017960A (cg-RX-API-DMAC7.html)
IT (1) IT1150100B (cg-RX-API-DMAC7.html)
NL (2) NL142595B (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51139613A (en) * 1975-05-24 1976-12-02 Nippon Shinyaku Co Ltd An absorbable non-crystalline sterol glycoside monopalmitate ester and a method for preparing its pharmaceutical
DE2530953C2 (de) * 1975-07-11 1994-07-07 Dr. Madaus & Co, 5000 Köln Verfahren zur Herstellung von röntgenamorphem Aescin, nach diesem Verfahren erhältliches röntgenamorphes Aescin und dieses enthaltende Arzneimittel
JPS5948810B2 (ja) * 1980-03-22 1984-11-29 山之内製薬株式会社 ニカルジピン持続性製剤用組成物
CN116115566B (zh) * 2021-11-15 2025-02-14 上海维洱生物医药科技有限公司 一种七叶皂苷钠脂质体及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2123248A (en) * 1937-01-14 1938-07-12 Louis N Markwood Insoluble reaction products of peat and process of making same
US2350804A (en) * 1939-07-22 1944-06-06 Ohta Masaki Derivatives of hesperidin and process for preparing the same
US2691654A (en) * 1952-06-11 1954-10-12 Buroughs Wellcome & Co U S A I Amino heterocycles and method of making
DE1134180B (de) * 1954-01-22 1962-08-02 Nitritfabrik Ges Mit Beschraen Verfahren zur Umwandlung von therapeutisch anwendbaren, in Wasser praktisch unloeslichen organischen Stoffen in ein echt wasserloesliches Produkt
US2780620A (en) * 1954-01-28 1957-02-05 Merle M Krider Partial acidic hydrolysis of steroidal saponins
US3110711A (en) * 1960-06-14 1963-11-12 Klinge Co Chem Pharm Fab Process of producing two escin isomers from horse chestnut extracts, and products

Also Published As

Publication number Publication date
NL142595B (nl) 1974-07-15
NL301747A (cg-RX-API-DMAC7.html)
IT1150100B (it) 1986-12-10
DK107183C (da) 1967-05-01
GB1017960A (en) 1966-01-26
AT245733B (de) 1966-03-10
US3238104A (en) 1966-03-01
FR3473M (fr) 1965-08-09
DE1282852B (de) 1968-11-14
DE1493999A1 (de) 1970-02-05
CH474541A (de) 1969-06-30

Similar Documents

Publication Publication Date Title
BE616386A (cg-RX-API-DMAC7.html)
BE627622A (cg-RX-API-DMAC7.html)
BE380301A (cg-RX-API-DMAC7.html)
BE613298A (cg-RX-API-DMAC7.html)
BE614380A (cg-RX-API-DMAC7.html)
BE630224A (cg-RX-API-DMAC7.html)
BE615523A (cg-RX-API-DMAC7.html)
BE614566A (cg-RX-API-DMAC7.html)
BE615316A (cg-RX-API-DMAC7.html)
BE612190A (cg-RX-API-DMAC7.html)
BE616166A (cg-RX-API-DMAC7.html)
BE613529A (cg-RX-API-DMAC7.html)
BE614739A (cg-RX-API-DMAC7.html)
BE592434A (cg-RX-API-DMAC7.html)
BE615244A (cg-RX-API-DMAC7.html)
NL301747A (cg-RX-API-DMAC7.html)
BE615294A (cg-RX-API-DMAC7.html)
BE612847A (cg-RX-API-DMAC7.html)
BE586180A (cg-RX-API-DMAC7.html)
BE614757A (cg-RX-API-DMAC7.html)
BE616920A (cg-RX-API-DMAC7.html)
BE629377A (cg-RX-API-DMAC7.html)
BE615962A (cg-RX-API-DMAC7.html)
BE608197A (cg-RX-API-DMAC7.html)
BE614986A (cg-RX-API-DMAC7.html)